In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals.

MLA

Iovleva, Alina, et al. “In Vitro Activity of Sulbactam-Durlobactam against Colistin-Resistant and/or Cefiderocol-Non-Susceptible, Carbapenem-Resistant Acinetobacter Baumannii Collected in U.S. Hospitals.” Antimicrobial Agents and Chemotherapy, vol. 68, no. 3, Mar. 2024, p. e0125823. EBSCOhost, https://doi.org/10.1128/aac.01258-23.

APA

Iovleva, A., McElheny, C. L., Fowler, E. L., Cober, E., Herc, E. S., Arias, C. A., Hill, C., Baum, K., Fowler, V. G., Jr, Chambers, H. F., Greenwood-Quaintance, K. E., Patel, R., van Duin, D., Bonomo, R. A., & Doi, Y. (2024). In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrobial Agents and Chemotherapy, 68(3), e0125823. https://doi.org/10.1128/aac.01258-23

Chicago

Iovleva, Alina, Christi L McElheny, Erin L Fowler, Eric Cober, Erica S Herc, Cesar A Arias, Carol Hill, et al. 2024. “In Vitro Activity of Sulbactam-Durlobactam against Colistin-Resistant and/or Cefiderocol-Non-Susceptible, Carbapenem-Resistant Acinetobacter Baumannii Collected in U.S. Hospitals.” Antimicrobial Agents and Chemotherapy 68 (3): e0125823. doi:10.1128/aac.01258-23.